首页> 美国卫生研究院文献>Annals of Translational Medicine >Chinese expert brief consensus on newborn screening of inherited metabolic disorders during the novel coronavirus infection epidemic
【2h】

Chinese expert brief consensus on newborn screening of inherited metabolic disorders during the novel coronavirus infection epidemic

机译:中国专家就新型冠状病毒感染流行期间新生儿遗传性代谢疾病的筛查达成简短共识

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Novel coronavirus (2019-nCov) infection (COVID-19) rapidly spread across China and 25 countries in the worldwide, which infected not only adults but also children, even neonates. Each year, about 15 million newborns are delivered in China. Newborn screening (NBS) helps effectively prevent some mental retardation, premature death, and adverse outcomes in the early stage of baby, which could detect some inherited metabolic disorders (IMDs). During this COVID-19 epidemic, how to balance the risk of infected 2019-nCov and the risk of disability and teratogenesis of IMDs. Expert members of NBS extra quality assessment in National Clinical Center of Laboratory (NCCL) give a brief consensus for NBS of IMDs in the COVID-2019 epidemic, hoping that the brief consensus could be reference for NBS of IMDs in the other epidemic areas or periods all over the world.
机译:新型冠状病毒(2019-nCov)感染(COVID-19)在中国和全球25个国家中迅速传播,不仅感染成年人,而且感染儿童,甚至是新生儿。每年,中国大约有1500万新生儿分娩。新生儿筛查(NBS)可帮助有效预防婴儿早期的某些智力障碍,过早死亡和不良后果,从而可以检测出某些遗传性代谢障碍(IMD)。在此COVID-19流行期间,如何平衡感染2019-nCov的风险与IMD致残和致畸的风险。国家实验室国家临床中心(NCCL)的NBS额外质量评估专家成员对COVID-2019流行病中的IMD的NBS达成了简短的共识,希望这一简短的共识可以为其他流行领域或时期的IMD的NBS提供参考。世界各地的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号